International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial

Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors

(2013) Daan Dierickx et al.   LEUKEMIA & LYMPHOMA

Early and Late Posttransplant Lymphoproliferative Disorder After Lung Transplantation—34 Cases From the European PTLD Network

(2013) Heiner Zimmermann et al.   TRANSPLANTATION

Posttransplantation Lymphoproliferative Disorder in Lung Transplant Recipients

(2013) Eli Muchtar et al.   TRANSPLANTATION

Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas

(2012) S. Caillard et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Burkitt post-transplantation lymphoma in adult solid organ transplant recipients

(2012) Heiner Zimmermann et al.   CANCER

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

(2011) Eric A. Engels et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

(2011) Ralf Trappe et al.   LANCET ONCOLOGY

Increased Risk for Lymphoid and Myeloid Neoplasms in Elderly Solid-Organ Transplant Recipients

(2010) S. C. Quinlan et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

(2010) Andrew M. Evens et al.   JOURNAL OF CLINICAL ONCOLOGY

A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation

(2008) Matthew J. Hourigan et al.   BRITISH JOURNAL OF HAEMATOLOGY